Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Alexander H Remels (Maastricht, Netherlands), Alexander Remels, Koen Verhees, Harry Gosker, Annemie Schols, Ramon Langen, Alexander Remels. Inactivation of glycogen synthase kinase 3β (GSK-3β) enhances skeletal muscle oxidative metabolism. Eur Respir J 2015; 46: Suppl. 59, 1226

Member's Comments

No comment yet.

Related content which might interest you: TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Inactivation of glycogen synthase kinase-3 is not required for recovery of muscle mass of disuse-atrophied muscle Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Skeletal muscle atrophy caused by acute pulmonary inflammation is dependent on a glycogen synthase kinase-3beta - glucocorticoid receptor signaling axis Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015 Hypoxia sensitizes skeletal muscle to fasting-induced muscle atrophy; role of AMPK activation Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Hypoxia-induced muscle atrophy and impaired regulation of protein turnover are partially dependent on muscle glucocorticoid receptor signaling Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Decreased expression of genes involved in skeletal muscle oxidative metabolism in COPD patients with muscle wasting Source: Annual Congress 2008 - Respiratory muscle pathophysiology Year: 2008 Pathways associated with reduced quadriceps oxidative fibres and endurance in COPD Source: Eur Respir J 2013; 41: 1275-1283 Year: 2013 Muscle morphology, metabolism and muscle function: general principles Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=86 Year: 2003 Impaired coordination of skeletal muscle protein turnover signalling in sarcopenic COPD patients Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Increased autophagy and reduced protein synthesis signaling are involved in pulmonary inflammation-induced skeletal muscle atrophy Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Effects of inflammation on skeletal muscle Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=68 Year: 2003 Inhibition of the glycogen synthase kinase 3β reduces steroid function in human monocytes Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 17: 939-945 Year: 2001 Skeletal muscle oxidative capacity is an independent predictor of physical activity in smokers with and without COPD Source: International Congress 2015 – Clinical physiology: mechanisms of symptoms and exercise limitations in health and disease Year: 2015 Inhibition of glycogen synthase kinase 3beta reduces GC function in human monocytes via modulation of HDAC2 activity Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 PPAR-γ activation inhibits TNF-α induced NF-κB activity in skeletal muscle cells Source: Eur Respir J 2006; 28: Suppl. 50, 620s Year: 2006 Impaired skeletal muscle kynurenine metabolism in patients with COPD Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Effects of exercise on ubiquitination and proteasome activity in skeletal muscle in COPD patients Source: Annual Congress 2012 - Exercise testing in disease Year: 2012 Regulation of airway smooth muscle RhoA/ROCK activities by cholinergic and bronchodilator stimuli Source: Eur Respir J 2006 Oct 01;28(4):703-711 Year: 2006 Decreased muscle PPAR concentrations: a mechanism underlying skeletal muscle abnormalities in COPD? Source: Eur Respir J 2007; 30: 191-193 Year: 2007